These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Authenticity and ambivalence: toward understanding the enhancement debate. Parens E Hastings Cent Rep; 2005; 35(3):34-41. PubMed ID: 16092400 [TBL] [Abstract][Full Text] [Related]
24. Evaluating life extension from a narrative perspective. Bunn A Am J Bioeth; 2009 Dec; 9(12):79-80. PubMed ID: 20013511 [No Abstract] [Full Text] [Related]
26. A man is a man is a man. Trachtman H Am J Bioeth; 2005; 5(3):31-3; discussion W4-9. PubMed ID: 16006346 [No Abstract] [Full Text] [Related]
27. Assessing the importance of maintaining soldiers' moral responsibility--possible trade-offs. Lev O Am J Bioeth; 2008 Feb; 8(2):44-5; discussion W4-6. PubMed ID: 18570078 [No Abstract] [Full Text] [Related]
28. Health care and the 'deserving poor'. Sher G Hastings Cent Rep; 1983 Feb; 13(1):9-12. PubMed ID: 6841065 [TBL] [Abstract][Full Text] [Related]
29. The reversal test: eliminating status quo bias in applied ethics. Bostrom N; Ord T Ethics; 2006 Jul; 116(4):656-79. PubMed ID: 17039628 [No Abstract] [Full Text] [Related]
30. Defending the distinction between treatment and enhancement. Schwartz PH Am J Bioeth; 2005; 5(3):17-9; discussion W4-9. PubMed ID: 16006367 [No Abstract] [Full Text] [Related]
31. Finding a context for discussing human life-extension. Jones DG; Whitaker MI Am J Bioeth; 2009 Dec; 9(12):77-9. PubMed ID: 20013510 [No Abstract] [Full Text] [Related]
32. Designer genes: an ethical perspective on genetic manipulation. Dreeman CJ Rutgers Comput Technol Law J; 1989; 15(2):447-74. PubMed ID: 16100798 [No Abstract] [Full Text] [Related]
33. Wanting everything done while others do without: an irony in American health care. Hamel R Second Opin; 1991 Jul; 17(1):126-30. PubMed ID: 10112029 [No Abstract] [Full Text] [Related]
34. Ethical preferences for the clinical practice of empowerment social work. Miley K; DuBois B Soc Work Health Care; 2007; 44(1-2):29-44. PubMed ID: 17521982 [TBL] [Abstract][Full Text] [Related]
36. One danger of biomedical enhancements. Rajczi A Bioethics; 2008 Jul; 22(6):328-36. PubMed ID: 18522592 [TBL] [Abstract][Full Text] [Related]
37. Clinical practice guidelines as tools of public policy: conflicts of purpose, issues of autonomy, and justice. Redman BK J Clin Ethics; 1994; 5(4):303-9. PubMed ID: 7749175 [No Abstract] [Full Text] [Related]
38. Slippery slopes, wonder drugs, and cosmetic neurology: the neuroethics of enhancement. Dees RH Neurology; 2004 Sep; 63(6):951-2. PubMed ID: 15452281 [No Abstract] [Full Text] [Related]
39. The stress of being a poor child in America. Garbarino J Child Adolesc Psychiatr Clin N Am; 1998 Jan; 7(1):105-19, ix. PubMed ID: 9894082 [TBL] [Abstract][Full Text] [Related]
40. Sexual dimorphism and the value of feminist bioethics. Matchett NJ Am J Bioeth; 2010 Jul; 10(7):18-20. PubMed ID: 20582821 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]